noom.semaglutide Noom Program Cost in 2026: Explore Pricing & Benefits Noom Med - GLP-1 Medications
Description
Discuss your specific medication schedule during your consultation to create an appropriate timeline
Mounjaro is the first and only approved once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist
Aesthetics + Medicine Under One Roof We uniquely integrate advanced cosmetic procedures, functional health, and primary care for lasting, inside-out results
Risk rises only if combined with insulin or insulin-stimulating medications like sulfonylureas
Common side effects observed in clinical trials include: Nausea Vomiting Diarrhea Stomach pain Constipation Weight loss Less common but serious side effects may include: Severe allergic reactions Thyroid tumors, including medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Pancreatitis Diabetic retinopathy complications Hypoglycemia, especially with other diabetes medications Worsening kidney disease Gallbladder disease and gallstones This is not a full list
Kristi Perry, PA-C Eli Luft, PA-C Key Takeaways 1
